These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6599698)

  • 1. Rapid eye movement (REM)-sleep during and after continuous infusion of the oxazoline derivate S3341: a comparison with clonidine.
    Lewis SJ; Jarrott B; Doyle AE
    J Hypertens Suppl; 1984 Dec; 2(3):S45-7. PubMed ID: 6599698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid eye movement sleep and the associated cardiovascular changes during and after continuous 10-day infusion of clonidine in normotensive rats: comparison with lofexidine and S3341.
    Lewis SJ; Jarrott B; Doyle AE
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):711-8. PubMed ID: 2442539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of continuous infusions (10 days) and cessation of infusions of clonidine and rilmenidine (S 3341) on cardiovascular and behavioral parameters of spontaneously hypertensive rats.
    Jarrott B; Lewis SJ; Doyle AE; Louis WJ
    Am J Cardiol; 1988 Feb; 61(7):39D-44D. PubMed ID: 2894156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males.
    Weerasuriya K; Shaw E; Turner P
    Eur J Clin Pharmacol; 1984; 27(3):281-6. PubMed ID: 6150856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects.
    Spiegel R; DeVos JE
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):165S-168S. PubMed ID: 6994771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clonidine infusion and withdrawal on blood pressure and behaviour in the rat. A preliminary study.
    Conway EL; Jarrott B
    Clin Exp Hypertens A; 1982; 4(8):1323-34. PubMed ID: 6889477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the involvement of alpha-2 adrenoceptors in the sedation but not REM sleep inhibition by clonidine in the rat.
    Mäkelä JP; Hilakivi IT
    Med Biol; 1986; 64(6):355-60. PubMed ID: 3029520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of central alpha adrenoceptors in the antihypertensive actions of methyldopa and clonidine in the rat.
    Jarrott B; Lewis S; Conway EL; Summers R; Louis WJ
    Clin Exp Hypertens A; 1984; 6(1-2):387-400. PubMed ID: 6321066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative analysis of the effects of clonidine preparations depending on methods of arterial pressure recording].
    Kunduzova OR; Murashev AN; Medvedeva NA; Medvedev OS
    Eksp Klin Farmakol; 1997; 60(6):10-2. PubMed ID: 9460588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of noradrenergic and GABA-ergic inputs in pedunculopontine tegmentum for regulation of rapid eye movement sleep in rats.
    Pal D; Mallick BN
    Neuropharmacology; 2006 Jul; 51(1):1-11. PubMed ID: 16616214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of alpha and beta adrenoceptors in locus coeruleus stimulation-induced reduction in rapid eye movement sleep in freely moving rats.
    Mallick BN; Singh S; Pal D
    Behav Brain Res; 2005 Mar; 158(1):9-21. PubMed ID: 15680190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral effects of S 3341 [(N-dicyclopropylmethyl)-amino-2-oxazoline] in animal models.
    van Zwieten PA; Thoolen MJ; Jonkman FA; Wilffert B; de Jonge A; Timmermans PB
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):130-49. PubMed ID: 2870686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum glucose and insulin levels in normotensive (WKY) and spontaneously hypertensive (SH) rats during and after the cessation of continuous (10 day) clonidine infusion.
    Lewis SJ; Dunlop M; Jarrott B
    J Pharm Pharmacol; 1989 May; 41(5):353-5. PubMed ID: 2569528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional brain concentrations of several putative peptide neurotransmitters in normotensive and spontaneously hypertensive rats: effects of continuous (10-day) clonidine infusion.
    Jarrott B; Lewis SJ; Louis WJ; Maccarrone C; Shulkes A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S14-21. PubMed ID: 2455167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic microinjection of alpha 2-adrenoceptor agonists causes greater sympathoinhibition in spontaneously hypertensive rats on high NaCl diets.
    Wyss JM; Yang RH; Jin HK; Oparil S
    J Hypertens; 1988 Oct; 6(10):805-13. PubMed ID: 2848885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contractile reactivity of isolated resistance arteries after 4 weeks of treatment with rilmenidine, clonidine or hydralazine in spontaneously hypertensive rats.
    Eerdmans PH; Struyker Boudier HA; De Mey JG
    J Hypertens Suppl; 1991 Dec; 9(6):S348-9. PubMed ID: 1818995
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of the alpha adrenoceptor-mediated effects and antihypertensive activity of ICI 106270: comparison with clonidine.
    Ruffolo RR; Yaden EL; Timmermans PB; van Zwieten PA; Hynes MD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):58-66. PubMed ID: 6323690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic injection with DSP-4 decreases the clonidine hypotension in bicuculline-treated rats.
    Gozlinska B; Czyźewska-Szafran H
    Res Commun Mol Pathol Pharmacol; 1999; 106(1-2):13-21. PubMed ID: 11127804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.